Study in Patients With Solid Tumor Regarding Access to Dermo-cosmetics and Aesthetic Solutions - Trial NCT05907551
Access comprehensive clinical trial information for NCT05907551 through Pure Global AI's free database. This phase not specified trial is sponsored by Institut de cancérologie Strasbourg Europe and is currently Not yet recruiting. The study focuses on Neoplasms. Target enrollment is 210 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
Institut de cancérologie Strasbourg Europe
Timeline & Enrollment
N/A
Jun 30, 2023
Oct 30, 2023
Primary Outcome
Describe patients' knowledges regarding cutaneous side-effects, nail and hair toxicities induced by anticancer drugs,Describe patients' knowledges regarding dermo-cosmetics and aesthetic solutions that can attenuate cutaneous side-effects, nail and hair toxicities induced by anticancer drugs
Summary
Cancer treatments can trigger cutaneous side-effects, as well as nail and hair toxicities.
 When related to drug treatment, this iatrogeny depends on the type of drug, its dosage and
 individual susceptibility. Although these dermatological adverse events are rarely serious,
 they can significantly alter patients' quality of life, and may even necessitate the
 introduction of curative treatment.
 
 The impact of these side effects can be mitigated by the use of dermo-cosmetic products and
 aesthetic solutions. However, most of this supportive care is not reimbursed by the health
 insurance system, representing a source of inequalities in access to healthcare for cancer
 patients.
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT05907551
Non-Device Trial